Operating
Change in receivables
Medtronic Change in receivables decreased by 106.1% to -$13.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 533.3%, from $3.00M to -$13.00M. Over 3 years (FY 2022 to FY 2025), Change in receivables shows relatively stable performance with a -3.2% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Significant fluctuations often reflect changes in supply chain financing arrangements or timing of payments from manufacturing partners.
Detailed definition
This broader metric includes changes in trade accounts receivable as well as other non-trade receivables, such as vendor...
Peer comparison
In complex global supply chains, this metric often fluctuates based on the timing of component purchasing and vendor rebates.
Metric ID:
cf_change_in_receivablesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | $131.00M | $41.00M | $265.00M | -$89.00M | $435.00M | $62.00M | $168.00M | -$164.00M | $281.00M | $23.00M | $251.00M | -$110.00M | $291.00M | $3.00M | $249.00M | -$288.00M | $214.00M | -$13.00M |
| QoQ Change | — | +227.5% | -68.7% | +546.3% | -133.6% | +588.8% | -85.7% | +171.0% | -197.6% | +271.3% | -91.8% | +991.3% | -143.8% | +364.5% | -99.0% | >999% | -215.7% | +174.3% | -106.1% |
| YoY Change | — | — | — | — | -322.5% | +232.1% | +51.2% | -36.6% | -84.3% | -35.4% | -62.9% | +49.4% | +32.9% | +3.6% | -87.0% | -0.8% | -161.8% | -26.5% | -533.3% |
Range-$288.00M – $435.00M
CAGR-22.1%
Avg YoY Growth-65.5%
Median YoY Growth-35.4%
Change in receivables at Other Companies
Frequently Asked Questions
- What is Medtronic's change in receivables?
- Medtronic (MDT) reported change in receivables of -$13.00M in Q4 2025.
- How has Medtronic's change in receivables changed year-over-year?
- Medtronic's change in receivables decreased by 533.3% year-over-year, from $3.00M to -$13.00M.
- What is the long-term trend for Medtronic's change in receivables?
- Over 3 years (2022 to 2025), Medtronic's change in receivables has grown at a -3.2% compound annual growth rate (CAGR), from $477.00M to $433.00M.
- What does change in receivables mean?
- The total change in all money owed to the company from both customers and other partners.